Previous Article | Next Article 
Infection and Immunity, September 2001, p. 5363-5374, Vol. 69, No. 9
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5363-5374.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Ongoing Horizontal and Vertical Transmission of Virulence Genes
and papA Alleles among Escherichia coli
Blood Isolates from Patients with Diverse-Source
Bacteremia
James R.
Johnson,1,2,*
Timothy T.
O'Bryan,1,2
Michael
Kuskowski,3,4 and
Joel N.
Maslow5,6
Medical Service1 and
Geriatric Research, Education, and Clinical
Center,3 Minneapolis VA Medical Center, and
Departments of Medicine2 and
Psychiatry,4 University of Minnesota,
Minneapolis, Minnesota, and Medical Service, Philadelphia
VA Medical Center,5 and Department of
Medicine, University of Pennsylvania,6
Philadelphia, Pennsylvania
Received 9 February 2001/Returned for modification 4 April
2001/Accepted 31 May 2001
 |
ABSTRACT |
The phylogenetic distributions of multiple putative virulence
factors (VFs) and papA (P fimbrial structural subunit)
alleles among 182 Escherichia coli blood isolates from
patients with diverse-source bacteremia were defined. Phylogenetic
correspondence among these strains, the E. coli
Reference (ECOR) collection, and other collections of extraintestinal
pathogenic E. coli (ExPEC) was assessed. Although among
the 182 bacteremia isolates phylogenetic group B2 predominated, exhibited the greatest concentration of individual VFs, and contained the largest number of familiar virulent clones, other phylogenetic groups exhibited greater concentrations of certain VFs than did group
B2 and included several additional virulent clones. Certain of the
newly detected VF genes, e.g., fyuA
(yersiniabactin; 76%) and focG (F1C fimbriae; 25%),
were as prevalent or more prevalent than their more familiar
traditional counterparts, e.g., iut (aerobactin; 57%)
and sfaS (S fimbriae; 14%), thus possibly offering
additional useful targets for preventive interventions. Considerable
diversity of VF profiles was observed at every level within the
phylogenetic tree, including even within individual lineages. This
suggested that many different pathways can lead to extraintestinal
virulence in E. coli and that the evolution of
ExPEC, which involves extensive horizontal transmission of VFs and
continuous remodeling of pathogenicity-associated islands, is
a highly active, ongoing process.
 |
INTRODUCTION |
The strains of
Escherichia coli that cause extraintestinal infections such
as urinary tract infection (UTI), meningitis, and bacteremia are
distinct both from most intestinal commensal E. coli types
and from diarrheagenic E. coli types (13, 57, 65, 70). These specialized extraintestinal pathogenic E. coli (ExPEC) strains (65) are thought to derive
primarily from E. coli phylogenetic group B2 (as defined
within the E. coli Reference [ECOR] collection by
multilocus enzyme electrophoresis [MLEE]) (20, 54) and to acquire their unique pathogenicity from their distinctive virulence factors (VFs) (4, 10, 59, 60).
Putative VFs of ExPEC include diverse adhesins, toxins, polysaccharide
coatings (including capsules and lipopolysaccharides), siderophores,
serum resistance mechanisms, and invasins (21, 33, 70).
Such VFs help the organisms colonize host surfaces, avoid and/or
subvert host defense mechanisms, injure and/or invade host cells and
tissues, and incite a noxious inflammatory response, thereby giving
rise to clinical disease (12, 21, 70). The VF genes of
ExPEC are thought to be primarily inherited vertically within
evolutionary lineages but also to be transferred horizontally between
lineages, in some instances on plasmids or on
"pathogenicity-associated islands" (PAIs), which are gene blocks
that contain multiple contiguous VF genes (2, 10, 16, 18, 36, 50,
61). Better understandings of the prevalence and evolutionary
origins of the VFs of ExPEC and of the distinctive "virulent
clones" that make up the ExPEC population should hasten the
development of the preventive measures that are sorely needed against
these morbid and costly infections (42, 43, 47, 55, 72).
Recent methodological and epidemiological developments now permit the
ready detection of a broad array of putative VFs of ExPEC (23,
27, 30, 33) and multiple F antigen-specific alleles of P
fimbrial structural subunit gene papA (25, 32, 35), all of which are potential candidates for VF-specific
preventive interventions such as vaccines (42, 43, 47,
55). We previously applied these developments to the analysis of
a collection of urosepsis isolates from Seattle, Wash. (30, 33,
35). We undertook the present study to gain an understanding of
the prevalence and phylogenetic distribution of such traits among
diverse-source E. coli bacteremia isolates.
Specifically, we analyzed a large collection of E. coli
blood isolates from patients with diverse-source bacteremia within
which phylogenetic relationships were previously established by MLEE
and for which O:H serotypes and selected VF markers have been reported
(22, 50). We sought to characterize this population with
respect to the prevalence and phylogenetic distribution of a broad
range of "newer" VFs and of the 12 recognized papA
alleles and to correlate the phylogenetic structure of this population
with that of the ECOR collection and other collections of ExPEC from
the literature.
 |
MATERIALS AND METHODS |
Strains.
The study population consisted of 182 of 187 previously published diverse-source E. coli bacteremia
isolates from hospitalized or community-dwelling adults
(50). (Five of the original 187 isolates were unavailable
for analysis.) These strains were previously characterized with respect
to genotype for papHC (P fimbriae), papEFG and
papG (P fimbrial adhesin) alleles, hly
(hemolysin), sfa and/or foc (S and F1C fimbriae),
iut (aerobactin system), bma (M fimbriae),
nfa (nonfimbrial adhesins), and afa and/or
dra (afimbrial and fimbrial Dr antigen-binding
adhesins); pulsed-field gel electrophoresis type;
mannose-resistant hemagglutination and hemolysin phenotypes; O:H
serotype; ribotype; and MLEE type (22, 50). Members of the
ECOR collection (54) were provided by Howard Ochman and
the American Type Culture Collection (Manassas, Va.). Strains were
stored in 20% glycerol at
70°C until use.
Virulence genotypes.
In the present study the 182 bacteremia
isolates were tested for 15 putative VF genes of ExPEC for which they
had not previously been tested. Detection was by dot blot hybridization
under stringent conditions, as previously described (27, 28,
33). Probes were generated and digoxigenin labeled using primers
as previously described (28, 33). The VF genes encompassed
five categories: adhesin, toxin, siderophore, capsule, and
miscellaneous genes. The adhesin genes investigated were
papAH (P fimbrial structural subunit), sfaS (S
fimbrial adhesin), focG (the putative F1C fimbrial adhesin),
and iha (iron-regulated gene homologue adhesin; a gene encoding a recently described putative adhesin found in ExPEC and
E. coli O157:H7) (30, 74). The siderophore
genes studied were fyuA (yersiniabactin) and iroN
(a novel putative catecholate siderophore). The toxin genes studied
were cnf1 (cytotoxic necrotizing factor) and cdtB
(cytolethal distending toxin). The capsule genes studied were
kpsMIITII and
kpsMIIITIII
(group II and group III capsular polysaccharide synthesis,
respectively). The miscellaneous VF genes were cvaC (colicin
V; multifunctional serum resistance-associated plasmids),
traT (serum resistance associated), ibeA
(invasion of brain endothelium), and malX, a marker
for a PAI from archetypal ExPEC strain CFT073 (18, 33,
36).
Strains also were tested by PCR for three VF gene regions, including
kpsMK1TK1 (K1
capsule synthesis),
kpsMIITII, and
sfaS, using primers and PCR conditions as previously
described (33). Strains that were positive for
kpsMIITII by
dot blot hybridization but not by PCR were considered to be K2 capsule
positive (33).
Strains that were positive for any pap element were tested
for 12 alleles of papA, corresponding to the 11 established
P fimbrial F types (F7-1, F7-2, and F8 to F16) plus the recently
discovered F48 papA variant, by using a multiplex PCR-based
assay, as previously described (23, 35).
Sequence determination of novel papA.
The
papA DNA sequence was determined as previously described
(35) for the three strains which were positive for
papAH by blotting and PCR but negative for a defined
papA allele in the allele-specific papA assay.
Predicted PapA peptides were aligned with reference PapA sequences for
traditional F types F7-1, F7-2, and F8 to F16 plus the recently
described F48 PapA variant (35) and PapA from strain 536 (25, 32) by using CLUSTAL-W (75). An unrooted
tree was inferred from the resulting PapA similarity matrix according
to the NJ method (66) by using the application MEGA
(40).
Phylogenetic comparison to the ECOR collection.
To relate
the known phylogenetic structure of the bacteremia isolates (as
previously defined by MLEE) (50) to the known phylogenetic
structure of the ECOR collection, a subset of the 182 strains
representing each of the four major phylogenetic divisions of the
bacteremia collection (i.e., clusters I, III, IV, and V) were
categorized as to ECOR phylogenetic group based on random amplified
polymorphic DNA (RAPD) analysis (3, 24, 26, 32, 34, 77).
Fingerprints were generated in duplicate for each strain using
(separately) arbitrary decamer primers 1247, 1254, and 1283 (3). Amplification conditions were as described previously (3) except that commercial PCR beads were used (3,
24, 26, 32, 34, 77). Each group of fingerprints from the three primers was combined in series to create a "virtual" composite fingerprint. Comparable fingerprints were generated in parallel for 10 ECOR control strains, including two from each of the five major ECOR
phylogenetic groups as defined by Herzer et al., based on
electrophoretic mobility polymorphisms (20). Each
bacteremia isolate was inferred to derive from the phylogenetic group
of the ECOR strain with which it exhibited the highest Pearson
correlation coefficient in pair-wise comparisons based on analog
densitometric scans of composite RAPD fingerprints (24, 26, 27,
32, 34).
Cluster analysis of VF profiles.
For a subset of the
bacteremia strains (i.e., those in electrophoretic type [ET]
47), a "tree" based on extended VF profiles was constructed
according to the unweighted pair group method with averaging (UPGMA)
(71) by using the application NT-SYSpc (Exeter Software,
Setauket, N.Y.).
Statistical methods.
Comparisons of proportions were tested
using Fisher's exact test (two tailed). Comparisons of the prevalences
of different traits within the same population were made using
McNemar's test (15). A VF score was calculated for each
strain as the sum of that for all VFs for which the strain was
positive, with values for the four pap regions
(papA, papHC, papEFG, and
papG) and the three sfa and/or foc
elements (sfa and/or foc, sfaS, and
focG) proportionally adjusted to account for multiple
detection of the same operon. Aggregate VF scores for groups were
compared using the Mann-Whitney U test. Correlations between VFs were
tested using the phi coefficient, a chi-square-based measure of
association for 2 by 2 tables. Because of multiple comparison, the
threshold for statistical significance was a P value of
<0.01, with a P value of <0.05 considered to reflect
borderline statistical significance.
Nucleotide sequence accession numbers.
Newly determined
papA sequences for strains CA033, CA039, and BOS020 were
deposited in GenBank under accession no. AF332518, AF332519, and
AF332520, respectively.
 |
RESULTS |
Prevalence of VFs and papA alleles.
All of the
newly assessed VFs were detected at least once in the population (Table
1). Among the adhesin genes, the recently described iha, although significantly less prevalent than
papA or papG (P < 0.001;
McNemar's test), was as prevalent as sfa and/or foc and was significantly more prevalent than the other
mannose-resistant adhesin genes assessed, i.e., afa and/or
dra, nfa, and bma (P < 0.001 for all comparisons; McNemar's test). focG was
significantly more prevalent than the better-known sialosyl-binding
adhesin gene sfaS (P = 0.008; McNemar's
test). Although hly was the most prevalent toxin gene,
cnf1 and diarrhea-associated cdtB also were appreciably prevalent. Among the siderophore genes, fyuA
(yersiniabactin), which only recently has been shown to occur in
E. coli (33, 67), was significantly more
prevalent than iut (aerobactin; P < 0.001;
McNemar's test), and the prevalence of recently described iroN approached that of iut. Nearly 80% of the
population exhibited group II capsule synthesis genes
(kpsMIITII),
with the K1 and the K2 variants accounting for 14 and 25% of
kpsMIITII-positive strains, respectively. Group III capsules were uncommon.
Meningitis-associated ibeA occurred in 12% of strains. The
PAI marker gene malX, present in 71% of strains, was the
second most prevalent trait after
kpsMIITII (Table 1).
All 12 established papA alleles were detected at least once
each in the population (Table 1). The recently described F48 papA variant (35) was the second most prevalent
papA allele overall (n = 20), after the F10
variant (n = 45) (Table 1). Six strains were positive
for papA by probe but negative for a defined papA
allele in the F type-specific papA allele PCR assay. From five of these, full-length papA amplicons could be
generated. Two of the papA amplicons repeatedly yielded
uninterpretable sequence data; both were from strains known to have two
copies of pap (not shown). Of the three amplicons that
yielded interpretable sequence data, two proved to represent variants
of the F11 papA allele. The third amplicon, from an isolate
in ET 42, was distant from the 12 papA alleles included in
the papA allele PCR assay but had 99.3% nucleotide identity
with papA from archetypal pyelonephritis isolate 536 (25, 32).
Phylogenetic distribution of VFs.
Projection of the VF and
papA allele data onto the MLEE-based phylogenetic tree
revealed diverse VF-specific patterns of distribution, which suggested
both vertical and horizontal transmission of VFs, plus selective
deletion of VFs from certain lineages (Fig.
1 and 2).
Vertical inheritance of VFs within lineages was suggested by the
significant concentration of specific VFs within particular phylogenetic groups, as was documented statistically at multiple hierarchical levels within the tree (Tables 1,
2, and 3).
At the most basal level of the tree, i.e., that of major clusters (I to
V), most VFs and papA alleles were significantly
concentrated within the most populous cluster, cluster III. Exceptions
included afa and/or dra (associated with cluster
I) and the F7-2 papA allele, iha,
iutA, and the K2 kpsMT variant (all associated
with cluster V) (Table 1). Aggregate VF scores were highest in cluster
III (median, 8.0; P < 0.001 versus all other strains
and versus cluster I, IV, or V). They were intermediate in cluster V
(median, 6.0; P > 0.10 versus all other strains and
P < 0.001 versus cluster I or IV), and lowest in
clusters I and IV (median, 2.0; P < 0.001 versus all
other strains; P > 0.10 for cluster I versus cluster IV).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 1.
Phylogenetic distribution of VF genes among 182 E. coli bacteremia isolates. The MLEE-based tree was
taken from Maslow et al. (50). Clusters I to V are
labeled. The four major subclusters within cluster III, i.e.,
subclusters A to D, are in boldface. Data reflect the number of
isolates within each lineage (Lin.) positive for the indicated trait.
Minus signs, absence of positivity for the indicated trait; n, number
of evaluatable isolates in the lineage.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 2.
Phylogenetic distribution of 12 F antigen-specific
papA alleles (F types) among 182 E. coli
bacteremia isolates. The MLEE-based tree is taken from Maslow et al.
(50). Clusters I to V are labeled. The four major
subclusters within cluster III, i.e., subclusters A to D, are in
boldface. Data reflect the number of isolates within each lineage
(Lin.) positive for the indicated papA allele. Minus
signs, absence of positivity for the indicated allele; n, number of
evaluatable isolates in the lineage. (In addition to the data shown,
strain BOS020 from lineage 42 was positive for the F536
papA allele according to comparative sequence
analysis.)
|
|
A nonrandom phylogenetic distribution of VFs was apparent also at the
level of the major subclusters (A to D) within cluster III (Table 2).
Here, however, no consistent pattern as to which subcluster exhibited
the greatest prevalence of specific traits emerged (Table 2). Similar
findings were also made at the level of the four groups of individual
lineages that made up subcluster C, the most populous subcluster within
cluster III (Table 3).
Exceptionally, particular VFs or papA alleles exhibited an
"all or none" pattern of phylogenetic distribution, either
occurring in all members of a phylogenetic group or being entirely
absent from the group. Most traits, however, if present at all occurred in only a fraction of the members of any particular phylogenetic group,
even if that group exhibited a significantly higher prevalence of the
trait than did comparable groups at the same hierarchical level in the
tree (Fig. 1 and 2; Tables 1 to 3). This phenomenon could be explained
by selective gene deletion from members of an ancestrally VF-positive
group and/or by horizontal entry of the trait into multiple smaller
branches of the tree in the absence of a VF-positive common ancestor.
Strongly favoring horizontal transfer in some instances was the
markedly discontinuous distribution of certain VFs across the tree,
with many intervening VF-negative lineages, a distribution pattern that
would require multiple deletion events if not due to horizontal
transfer (Fig. 1 and 2; Tables 1 to 3). Even more compelling evidence
of horizontal transfer was provided by the distribution of
papA alleles, since adjacent lineages commonly exhibited
different alleles, whereas each shared its particular allele with
phylogenetically distant lineages (Fig. 2; Table 3). Moreover, many
individual lineages exhibited diverse papA alleles among
their various members. These phenomena could not be explained by
selective deletion alone and instead suggested horizontal exchange of
papA alleles between lineages, possibly even independent of
other pap elements.
Ordered diversity of VF genotypes within an individual
lineage.
Because of limiting numbers, statistical comparisons of
aggregate VF data (e.g., Tables 1 to 3) could not be made at the level
of the individual lineages (i.e., ETs) within the lineage groups shown in Table 3, although diversity of VF profiles was still apparent even at this level (Fig. 1 and 2). However, ET 47, the
single most populous lineage overall, provided an opportunity to
analyze the continuing diversity of VF profiles even at the most
differentiated extreme of the phylogenetic tree. The members of ET 47 exhibited seven distinct papA alleles and two
papG allele configurations and were variably positive for
most of the other traits detected within this lineage, with only
fyuA,
kpsMIITII, and
the PAI marker being universally prevalent (Fig.
3). Analysis of the VF and
papA allele data for ET 47 by UPGMA revealed that these
traits were not randomly distributed (Fig. 3). Instead, they segregated
in an arborizing pattern that could be explained most parsimoniously by
the sequential acquisition or loss of specific markers by separate
subclones within this lineage as the subclones progressively
differentiated from a common ancestor (Fig. 3).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Cluster analysis of VF and papA allele
data for ET 47. Dendrogram (according to UPGMA) reflects similarity
relationships based on VF and papA allele profiles among
isolates from ET 47, which have indistinguishable genomic backgrounds
according to MLEE. Strain CA039 was negative in the F PCR assay but
contained a papA variant most similar to the F48
papA allele according to comparative sequence
analysis.
|
|
Associations between individual VFs.
Analysis of the total VF
data set revealed many familiar patterns of association between VFs
(23, 30, 33, 35). These included the positive associations
among "J96-like" traits sfa and/or foc,
hly, cnf1, and papG allele III, as a
group, and among "CFT073-like" traits iha, iut,
papG allele II,
kpsMIITII, and the K2 kpsMT variant, as a group, together with the
generally negative associations between these two groups (Fig.
4). Also of note were the negative
associations of afa and/or dra and nfa with sfa and/or foc, the association of
ibeA with the (meningitis-associated) K1 kpsMT
variant, and the absence of an association between iha and
the PAI marker gene malX despite their close physical
proximity on the same PAI in archetypal strain CFT073 (18,
36).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 4.
Correlations among VF genes for 182 E.
coli bacteremia isolates. Only those VF genes that yielded at
least one correlation at the P 0.01 level are
shown. Results for papA were similar to those for
papG. Significance levels: , P > 0.01; +, P 0.01; ++, P 0.001. (Parentheses denote negative associations.)
|
|
The various papA alleles also exhibited multiple distinctive
associations with specific VF genes (Fig.
5). Of note were the nonoverlapping
groups of papA alleles associated with certain closely
related VF genes such as papG allele II versus allele III,
sfaS versus focG, and the various
kpsMT variants (Fig. 5). Also of note were the shared
associations of hly and cnf1 with the F13, F14,
and F48 papA alleles but the specific associations of
hly with the F7-2 papA allele and of
cnf1 with the F12 papA allele (Fig. 5).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 5.
Correlations among F antigen-specific
papA alleles and other VF genes for 182 E.
coli bacteremia isolates. Only those papA
alleles that yielded at least one correlation at the
P 0.01 level are shown. Significance levels: ,
P > 0.01; +, P 0.01; ++,
P 0.001. (Parentheses denote negative
associations.)
|
|
Comparisons among the papA alleles themselves revealed
associations between the F8 allele and both the F9 and F10 alleles (P < 0.01), between the F14 and F16 alleles
(P < 0.001), and between the F9 and F13 alleles
(P < 0.001). Many additional associations were noted
at the level of P < 0.05 (not shown).
Correspondence of the present population with ECOR groups and with
known virulent clones.
Composite RAPD analysis revealed that
clusters I, III, IV, and V of the present population (Fig. 1 and 2)
correspond, respectively, with ECOR phylogenetic groups A, B2, B1, and
D, as defined by MLEE (not shown). These findings, together with
previously determined serotypes for the present population
(50), the VF and papA data from the present
study, and selective additional comparative RAPD analyses (not shown),
allowed certain lineages to be presumptively linked with recognized
virulent clones of ExPEC (Table 4). Of note, two of the distinct pathotypic groups within ET 47 (Fig. 3), one
characterized by the F12 papA allele, papG allele
III, and both hly and cnf and the other
characterized by the F7-2 papA allele, papG
allele II, and hly but not cnf, corresponded to
two recognized virulence-associated clones within serogroup O6 (Table 4). Because of the multiple VF profile subdivisions within ET 47 (Fig.
3), ET 42, which was the second most populous lineage overall but which
in comparison with ET 47 was pathotypically fairly homogeneous (Fig. 1
and 2), emerged as the most prevalent clonopathotype (not shown). This
ET, one of whose members (BOS020) exhibited the recently described
"F536" papA variant, putatively corresponds to an
O6:K+;F48/F536-positive lineage, which is a prominent cause of UTI in
dogs, cats, and humans and which includes archetypal pyelonephritis
isolate 536 (Table 4).
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Proposed correspondence between specific lineages from
present study and recognized virulent clones of ExPEC
|
|
 |
DISCUSSION |
In the present study we assessed the phylogenetic distribution of
multiple VF genes and papA alleles among E. coli isolates from patients with diverse-source bacteremia and
defined the phylogenetic correspondence between these strains, the ECOR
collection, and other collections of ExPEC. We found that although
among the bacteremia isolates phylogenetic group B2 predominated
overall, other phylogenetic groups exhibited greater concentrations of
certain VFs than did group B2 and included several additional
recognized virulent clones. Moreover, certain of the newly detected VFs
were as prevalent or more prevalent than their more familiar
traditional counterparts, thus possibly constituting additional useful
targets for preventive interventions. The considerable diversity of VF
profiles observed at every level within the phylogenetic tree,
including even within individual lineages, suggested that many
different pathways can lead to extraintestinal virulence in E. coli and that the evolution of ExPEC, which involves extensive
horizontal transmission of VFs and continuous remodeling of PAIs, is an
active, ongoing process.
Our results are consistent with previous evidence that E. coli phylogenetic group B2 predominates among ExPEC and is the
main repository (hence, presumably, the original source within the species) of many extraintestinal VFs (10, 23, 33, 45, 59,
60). Our data considerably enlarge the range of VFs known to be
associated with phylogenetic group B2 in the context of diverse-source
bacteremia (22, 50). However, they also demonstrate that
certain VFs are significantly concentrated outside of group B2 in
phylogenetic group A or D or are broadly distributed in the population
without a focal concentration in any one phylogenetic group. This is
consistent with recent findings derived from analysis of the ECOR
collection and urosepsis isolates (23, 30, 33). The latter
observations suggest that the evolutionary histories of the various VFs
of ExPEC are more complex and diverse than can be accounted for by
two-step models that focus primarily on phylogenetic group B2, as
previously proposed based on an analysis of pap,
hly, sfa and/or foc, and
kps (10, 45).
The broad range of our VF gene screening allowed us to document an
appreciable prevalence and/or nonrandom phylogenetic distribution for
many newer VF genes, including iha, fyuA,
iroN, cnf, cdt, and ibeA. Likewise, by
discriminating between closely related variants of a particular VF gene
or gene family we were able to detect disparate associations,
prevalences, and phylogenetic backgrounds for the 12 papA
alleles, sfaS versus focG, and the several
kpsMT variants. This simultaneously broad and highly
discriminating approach to VF genotyping provided the added advantage
of generating distinctive extended VF "signatures" for individual
strains and lineages. In many instances, with or without supplemental
data these signatures allowed us to associate lineages from the present population with known virulent clones from the literature (Table 4).
For example, we found that an O6:K+;F48/F536 clonal group that is
associated with UTI in animals and humans (unpublished data; 25,
27, 34) and that includes archetypal pyelonephritis isolate 536 (8) was the single most prevalent clonopathotype in the
study population. It accounted for ~7% of isolates overall, and its
isolates outnumbered even those of the prominent O6:K2:H1 clonal group
(~4%). The associated primary sources of bacteremia for these
O6:K+;F48/F536 strains included UTI, pneumonitis, and intra-abdominal
infections (49). The evident pathogenetic versatility of
this clone with respect to host species, clinical syndrome, and
anatomical site of infection illustrates the inappropriateness of the
traditional designation of uropathogenic E. coli and
supports instead a more inclusive rubric such as ExPEC
(65). Consistent with this "generalist" concept, we
identified within the study population several representatives of the
O18:K1:H7 clonal group, which traditionally has been associated with
neonatal meningitis (9, 38, 69) but which recently was
shown to be a major contributor also to uncomplicated cystitis in women
(24, 26, 41).
Correlation of the newly detected VFs, and especially the
papA alleles, with the population's underlying phylogenetic
structure suggested even more extensive horizontal transfer of VFs than was previously proposed for this population based on analysis of
pap, hly, sfa and/or foc,
afa and/or dra, and iut
(50) or the three papG alleles
(22). The evidence of horizontal transfer extended down to
the most differentiated subdivisions of the phylogenetic tree, i.e.,
the individual ETs themselves, and beyond. This suggests that ExPEC
strains are actively evolving with respect to VF profiles even
today and hence represent a "moving target" for the pathotypic analyses that are needed to guide the development of VF-specific protective measures. Moreover, the ordered diversity of VF profiles observed within ET 47 (Fig. 3) suggests ongoing evolution of the genomic background at a level below the detection threshold of MLEE,
which is insensitive to silent mutations and to peptide polymorphisms
that do not alter the electrophoretic mobility of the particular
markers analyzed (68, 79). We propose that in the instance
of ET 47 the VF data, rather than being phylogenetically unreliable (as
was previously suggested when diverse pathotypes were encountered
within a single electrophoretic lineage) (69), actually
supersede MLEE by revealing significant evolutionary diversity that
MLEE is unable to detect. Formal testing of this hypothesis should be
possible with the use of a phylotyping method more discriminating than
MLEE, e.g., multilocus sequence typing (14, 45, 48, 63).
Although the strict clinical criteria for inclusion in the present
study population (50) represent an epidemiological
strength of the study, they do limit the generalizability of the
findings to the larger E. coli population. The requirement
that isolates must have caused bacteremia imposes a substantial
"filter" that is predicted to bias the population not only toward
the more virulent phylogenetic groups such as B2 and D (i.e., clusters
III and V) but also toward the more virulent members within each group.
This filtering effect would probably be strongest for intrinsically "low-virulence" groups such as A and B1 (i.e., clusters I and IV),
most members of which may lack VFs and hence would be unable to cause
bacteremia except in the presence of significant host compromise
(23, 60). Consistent with this hypothesis, multiple VFs
were numerically more prevalent within cluster I of the present population (group A equivalent) than among the group A ECOR strains (23). The genes for these included afa and/or
dra (29 versus 0%), iut (52 versus 24%),
kpsMIITII (48 versus 20%), traT (29 versus 16%), and nfa,
kpsIIIMTIII,
and malX (all 10 versus 0%). In contrast, only two VF genes
were more prevalent among the group A ECOR strains, i.e.,
iha (28 versus 10%) and fyuA (52 versus 24%)
(23). Similar trends were evident when cluster IV of the present population (group B1 equivalent) was compared with the group B1
ECOR strains (not shown) (23). Thus, broad phylogenetic conclusions must be tempered by recognition of the likely substantial influence of clinical context on the observed associations.
Previous studies have documented that PAIs from different ExPEC strains
can differ considerably with respect to their constituent VF
genes (9, 18, 19, 64, 73) and, for those VF genes that do consistently occur together in multiple PAIs, the specific genetic linkages between the VF genes (46). These largely
anecdotal observations, together with our present population-based
finding that even VFs known to be PAI associated in certain strains
commonly exhibit divergent patterns of phylogenetic distribution both
among lineages and even within a given lineage, strongly suggest that VF genes are highly mobile independent of PAIs and that PAIs are subject to continuous, ongoing remodeling. These data are consistent with a model in which PAIs, although perhaps occasionally subject to en
bloc horizontal transfer (10, 16) or total deletion (5, 8, 19, 37), participate to a much greater extent in
the horizontal transfer of VFs by providing genomic regions receptive
to the insertion, retention, and release of individual VF genes.
The abundance of recombination-promoting elements within PAIs
(16) presumably allows for the ready acquisition of any
"wandering" VF genes that happen to enter the cell, plus ready
deletion of previously integrated VF genes, including their donation to
nearby plasmids, transposons, etc. The resulting rapid reassortment of VF genes within PAIs continuously generates novel combinations of VFs
on which selective pressures can act. Those combinations of VFs that
increase fitness in a particular niche or that broaden the range of
niches in which the host cell can effectively compete are conserved and
expand with the clone. However, just as the clonal frame of the
bacterial host's (presumably selection-neutral) genomic background
gradually breaks down over time from recombined genomic regions
(17, 44, 51), so too is the host's highly selectable VF
profile (i.e., the architecture of its PAIs) disrupted by newly
acquired and deleted VF genes. According to this model, PAIs are not so
much horizontally mobile and internally stable as they are horizontally
stable but internally highly dynamic. Long-range VF mapping
(7), comparative genomic analysis (6), and
long-term culture experiments involving clonally mixed populations may
allow direct testing of this model in the future.
In summary, we found that among E. coli blood isolates from
patients with diverse-source bacteremia, phylogenetic group B2 predominated overall and accounted for most of the individual VFs and
virulent clones. However, other phylogenetic groups exhibited greater
concentrations of certain VFs than did group B2 and accounted for
additional virulent clones. Certain newly detected VFs were as
prevalent or more prevalent than were their more familiar counterparts and hence may constitute useful targets for future preventive interventions. The considerable diversity of VF profiles noted at every
level within the phylogenetic tree suggests that many different
pathways can lead to extraintestinal virulence in E. coli
and that the evolution of ExPEC, which involves extensive horizontal
transmission of VFs and continuous remodeling of PAIs, is a highly
active and ongoing process.
 |
ACKNOWLEDGMENTS |
This work was supported by the Office of Research and
Development, Medical Research Service, Department of Veterans Affairs (J.R.J. and J.N.M.), National Institutes of Health grant DK-47504 (J.R.J), and National Research Initiative (NRI) Competitive Grants Program/United States Department of Agriculture grant 00-35212-9408 (J.R.J.).
Dave Prentiss (Minneapolis VAMC) helped prepare the figures. Ann Emery
(Minneapolis VAMC) helped with manuscript preparation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Infectious
Diseases (111F), VA Medical Center, One Veterans Dr., Minneapolis, MN
55417. Phone: (612) 725-2000, ext. 4185. Fax: (612) 727-5995. E-mail: johns007{at}tc.umn.edu.
Editor:
A. D. O'Brien
 |
REFERENCES |
| 1.
|
Achtman, M.,
A. Mercer,
B. Kusecek,
A. Pohl,
M. Heuzenroeder,
W. Aaronson,
A. Sutton, and R. P. Silver.
1983.
Six widespread bacterial clones among Escherichia coli K1 isolates.
Infect. Immun.
39:315-335[Abstract/Free Full Text].
|
| 2.
|
Arthur, M.,
R. D. Arbeit,
C. Kim,
P. Beltran,
H. Crowe,
S. Steinback,
C. Campanelli,
R. A. Wilson,
R. K. Selander, and R. Goldstein.
1990.
Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons.
Infect. Immun.
58:471-479[Abstract/Free Full Text].
|
| 3.
|
Berg, D. E.,
N. S. Akopyants, and D. Kersulyte.
1994.
Fingerprinting microbial genomes using the RAPD or AP-PCR method.
Methods Mol. Cell. Biol.
5:13-24.
|
| 4.
|
Bingen, E.,
B. Picard,
N. Brahimi,
S. Mathy,
P. Desjardins,
J. Elion, and E. Denamur.
1998.
Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains.
J. Infect. Dis.
177:642-650[Medline].
|
| 5.
|
Bloch, C. A., and C. K. Rode.
1996.
Pathogenicity island evaluation in Escherichia coli K1 by crossing with laboratory strain K-12.
Infect. Immun.
64:3218-3223[Abstract].
|
| 6.
|
Bloch, C. A.,
C. K. Rode,
V. Obreque, and K. Y. Russell.
1994.
Comparative genome mapping with mobile physical map landmarks.
J. Bacteriol.
176:7121-7125[Abstract/Free Full Text].
|
| 7.
|
Blum, G.,
M. Ott,
A. Cross, and J. Hacker.
1991.
Virulence determinants of Escherichia coli O6 extraintestinal isolates analysed by Southern hybridizations and DNA long range mapping techniques.
Microb. Pathog.
10:127-136[CrossRef][Medline].
|
| 8.
|
Blum, G.,
M. Ott,
A. Lischewski,
A. Ritter,
H. Imrich,
H. Tschape, and J. Hacker.
1994.
Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen.
Infect. Immun.
62:606-614[Abstract/Free Full Text].
|
| 9.
|
Bonacorsi, S. P. P.,
O. Clermont,
C. Tinsley,
I. Le Gall,
J.-C. Beaudoin,
J. Elion,
X. Nassif, and E. Bingen.
2000.
Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains.
Infect. Immun.
68:2096-2101[Abstract/Free Full Text].
|
| 10.
|
Boyd, E. F., and D. L. Hartl.
1998.
Chromosomal regions specific to pathogenic isolates of Escherichia coli have a phylogenetically clustered distribution.
J. Bacteriol.
180:1159-1165[Abstract/Free Full Text].
|
| 11.
|
Cherifi, A.,
M. Contrepois,
B. Picard,
P. Oullet,
I. Orskov,
F. Orskov, and J. De Rycke.
1991.
Clonal relationships among Escherichia coli serogroup O6 isolates from human and animal infections.
FEMS Microbiol. Lett.
80:225-230[CrossRef].
|
| 12.
|
Donnenberg, M. S., and R. A. Welch.
1996.
Virulence determinants of uropathogenic Escherichia coli, p. 135-174.
In
H. L. T. Mobley, and J. W. Warren (ed.), Urinary tract infections: molecular pathogenesis and clinical management. ASM Press, Washington, D.C.
|
| 13.
|
Eisenstein, B. I., and G. W. Jones.
1988.
The spectrum of infections and pathogenic mechanisms of Escherichia coli.
Adv. Intern. Med.
33:231-252[Medline].
|
| 14.
|
Enright, M. C., and B. C. Spratt.
1999.
Multilocus sequence typing.
Trends Microbiol.
7:482-487[CrossRef][Medline].
|
| 15.
|
Fleiss, J. L.
1981.
Statistical methods for rates and proportions, p. 112-137.
John Wiley & Sons, New York, N.Y.
|
| 16.
|
Groisman, E. A., and H. Ochman.
1996.
Pathogenicity islands: bacterial evolution in quantum leaps.
Cell.
87:791-794[CrossRef][Medline].
|
| 17.
|
Guttman, D. S., and D. E. Dykhuizen.
1994.
Clonal divergence in Escherichia coli as a result of recombination, not mutation.
Science
266:1380-1383[Abstract/Free Full Text].
|
| 18.
|
Guyer, D. M.,
J.-S. Kao, and H. L. T. Mobley.
1998.
Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and catheter-associated bacteriuria and from fecal samples.
Infect. Immun.
66:4411-4417[Abstract/Free Full Text].
|
| 19.
|
Hacker, J.,
L. Bender,
M. Ott,
J. Wingender,
B. Lund,
R. Marre, and W. Goebel.
1990.
Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates.
Microb. Pathog.
8:213-225[CrossRef][Medline].
|
| 20.
|
Herzer, P. J.,
S. Inouye,
M. Inouye, and T. S. Whittam.
1990.
Phylogenetic distribution of branched RNS-linked multicopy single-stranded DNA among natural isolates of Escherichia coli.
J. Bacteriol.
172:6175-6181[Abstract/Free Full Text].
|
| 21.
|
Johnson, J. R.
1991.
Virulence factors in Escherichia coli urinary tract infection.
Clin. Microbiol. Rev.
4:80-128[Abstract/Free Full Text].
|
| 22.
|
Johnson, J. R.,
J. J. Brown, and J. N. Maslow.
1998.
Clonal distribution of the three alleles of the Gal( 1-4)Gal-specific adhesin gene papG among Escherichia coli strains from patients with bacteremia.
J. Infect. Dis.
177:651-661[Medline].
|
| 23.
|
Johnson, J. R.,
P. Delavari,
M. Kuskowski, and A. L. Stell.
2001.
Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli.
J. Infect. Dis.
183:78-88[CrossRef][Medline].
|
| 24.
|
Johnson, J. R.,
P. Delavari, and T. O'Bryan.
2001.
Escherichia coli O18:K1:H7 isolates from acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profiles.
J. Infect. Dis.
183:425-434[CrossRef][Medline].
|
| 25.
|
Johnson, J. R.,
P. Delavari,
A. L. Stell,
T. S. Whittam,
U. Carlino, and T. A. Russo.
2001.
Molecular comparison of extraintestinal Escherichia coli isolates from the same electrophoretic lineages from humans and domestic animals.
J. Infect. Dis.
183:154-159[CrossRef][Medline].
|
| 26.
|
Johnson, J. R.,
T. T. O'Bryan,
P. Delavari,
M. Kuskowski,
A. Stapleton,
U. Carlino, and T. Russo.
2001.
Clonal relationships and extended virulence genotypes among Escherichia coli isolates from women with a first or recurrent episode of cystitis.
J. Infect. Dis.
183:1508-1517[CrossRef][Medline].
|
| 27.
|
Johnson, J. R.,
T. T. O'Bryan,
D. A. Low,
G. Ling,
P. Delavari,
C. Fasching,
T. A. Russo,
U. Carlino, and A. L. Stell.
2000.
Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele III.
Infect. Immun.
68:3327-3336[Abstract/Free Full Text].
|
| 28.
|
Johnson, J. R.,
T. A. Russo,
J. J. Brown, and A. Stapleton.
1998.
papG alleles of Escherichia coli strains causing first episode or recurrent acute cystitis in adult women.
J. Infect. Dis.
177:97-101[Medline].
|
| 29.
|
Johnson, J. R.,
T. A. Russo,
F. Scheutz,
J. J. Brown,
L. Zhang,
K. Palin,
C. Rode,
C. Bloch,
C. F. Marrs, and B. Foxman.
1997.
Discovery of disseminated J96-like strains of uropathogenic Escherichia coli O4:H5 containing genes for both PapGJ96 ("class I") and PrsGJ96 ("class III") Gal( 1-4)Gal-binding adhesins.
J. Infect. Dis.
175:983-988[Medline].
|
| 30.
|
Johnson, J. R.,
T. A. Russo,
P. I. Tarr,
U. Carlino,
S. S. Bilge,
J. C. J. Vary, and A. L. Stell.
2000.
Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroNE. coli, among Escherichia coli isolates from patients with urosepsis.
Infect. Immun.
68:3040-3047[Abstract/Free Full Text].
|
| 31.
|
Johnson, J. R.,
A. E. Stapleton,
T. A. Russo,
F. S. Scheutz,
J. J. Brown, and J. N. Maslow.
1997.
Characteristics and prevalence within serogroup O4 of a "J96-like" clonal group of uropathogenic Escherichia coli O4:H5 containing the "class I" and "class III" alleles of papG.
Infect. Immun.
65:2153-2159[Abstract].
|
| 32.
|
Johnson, J. R.,
A. Stell, and P. Delavari.
2001.
Canine feces as a reservoir of extraintestinal pathogenic Escherichia coli.
Infect. Immun.
69:1306-1314[Abstract/Free Full Text].
|
| 33.
|
Johnson, J. R., and A. L. Stell.
2000.
Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.
J. Infect. Dis.
181:261-272[CrossRef][Medline].
|
| 34.
|
Johnson, J. R.,
A. L. Stell,
P. Delavari,
A. C. Murray,
M. Kuskowski, and W. Gaastra.
2001.
Phylogenetic and pathotypic similarities between Escherichia coli isolates from urinary tract infections in dogs and extraintestinal infections in humans.
J. Infect. Dis.
183:897-906[CrossRef][Medline].
|
| 35.
|
Johnson, J. R.,
A. L. Stell,
F. Scheutz,
T. T. O'Bryan,
T. A. Russo,
U. B. Carlino,
C. C. Fasching,
J. Kavle,
L. van Dijk, and W. Gaastra.
2000.
Analysis of F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay.
Infect. Immun.
68:1587-1599[Abstract/Free Full Text].
|
| 36.
|
Kao, J.-S.,
D. M. Stucker,
J. W. Warren, and H. L. T. Mobley.
1997.
Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains.
Infect. Immun.
65:2812-2820[Abstract].
|
| 37.
|
Knapp, S.,
J. Hacker,
I. Then,
D. Muller, and W. Goebel.
1984.
Multiple copies of hemolysin genes and associated sequences in the chromosomes of uropathogenic Escherichia coli strains.
J. Bacteriol.
159:1027-1033[Abstract/Free Full Text].
|
| 38.
|
Korhonen, T. K.,
M. V. Valtonen,
J. Parkkinen,
V. Vaisanen-Rhen,
J. Fine,
F. Orskov,
I. Orskov,
S. B. Svenson, and P. H. Makela.
1985.
Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis.
Infect. Immun.
48:486-491[Abstract/Free Full Text].
|
| 39.
|
Korhonen, T. K.,
R. Virkola,
V. Vaisanen-Rhen, and H. Holthofer.
1986.
Binding of purified Escherichia coli O75X adhesin to frozen sections of human kidney.
FEMS Lett.
35:313-318[CrossRef].
|
| 40.
|
Kumar, S.,
K. Tamura, and M. Nei.
1993.
MEGA: Molecular Evolutionary Genetics Analysis, version 1.01.
The Pennsylvania State University, University Park, Pa.
|
| 41.
|
Kunin, C. M.,
T. H. Hua,
C. Krishnan,
L. Van Arsdale White, and J. Hacker.
1993.
Isolation of a nicotinamide-requiring clone of Escherichia coli O18:K1:H7 from women with acute cystitis: resemblance to strains found in neonatal meningitis.
Clin. Infect. Dis.
16:412-416[Medline].
|
| 42.
|
Langermann, S.,
R. Mollby,
J. E. Burlein,
S. R. Palaszynski,
C. G. Auguste,
A. DeFusco,
R. Strouse,
M. A. Schenerman,
S. J. Hultgren,
S. Pinkner,
J. Winberg,
L. Guldevall,
M. Soderhall,
K. Ishikawa,
S. Normark, and S. Koenig.
2000.
Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
J. Infect. Dis.
181:774-778[CrossRef][Medline].
|
| 43.
|
Langermann, S.,
S. Palaszynski,
M. Barnhart,
G. Auguste,
J. S. Pinkner,
J. Burlein,
P. Barren,
S. Koenig,
S. Leath,
C. H. Jones, and S. J. Hultgren.
1997.
Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
Science
276:607-611[Abstract/Free Full Text].
|
| 44.
|
Lawrence, J. G., and H. Ochman.
1998.
Molecular archaeology of the Escherichia coli genome.
Evolution
95:9413-9417.
|
| 45.
|
Lecointre, G.,
L. Rachdi,
P. Darlu, and E. Denamur.
1998.
Escherichia coli molecular phylogeny using the incongruence length difference test.
Mol. Biol. Evol.
15:1685-1695[Abstract].
|
| 46.
|
Low, D.,
V. David,
D. Lark,
G. Schoolnik, and S. Falkow.
1984.
Gene clusters governing the production of hemolysin and mannose-resistant hemagglutination are closely linked in Escherichia coli serotype O4 and O6 isolates from urinary tract infection.
Infect Immun.
43:353-358[Abstract/Free Full Text].
|
| 47.
|
Lund, B.,
F. Lindberg,
B.-I. Marklund, and S. Normark.
1988.
Tip proteins of pili associated with pyelonephritis: new candidates for vaccine development.
Vaccine
6:110-112[CrossRef][Medline].
|
| 48.
|
Maiden, C. J.,
J. A. Bygraves,
E. Feil,
G. Morelli,
J. E. Russwell,
R. Urwin,
Q. Zhang,
J. Zhou,
K. Zurth,
D. A. Caugant,
I. M. Feavers,
M. Achtman, and B. G. Spratt.
1998.
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.
Proc. Natl. Acad. Sci. USA
95:3140-3145[Abstract/Free Full Text].
|
| 49.
|
Maslow, J. N.,
M. E. Mulligan,
K. S. Adams,
J. C. Justis, and R. D. Arbeit.
1993.
Bacterial adhesins and host factors: role in the development and outcome of Escherichia coli bacteremia.
Clin. Infect. Dis.
17:89-97[Medline].
|
| 50.
|
Maslow, J. N.,
T. S. Whittam,
C. F. Gilks,
R. A. Wilson,
M. E. Mulligan,
K. S. Adams, and R. D. Arbeit.
1995.
Clonal relationships among bloodstream isolates of Escherichia coli.
Infect. Immun.
63:2409-2417[Abstract].
|
| 51.
|
Milkman, R., and M. M. Bridges.
1990.
Molecular evolution of the Escherichia coli chromosome. III. Clonal frames.
Genetics
126:505-517[Abstract].
|
| 52.
|
Mobley, H. L. T.,
K. G. Jarvis,
J. P. Elwood,
D. I. Whittle,
C. V. Lockatell,
R. G. Russell,
D. E. Johnson,
M. S. Donnenberg, and J. W. Warren.
1993.
Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of Gal(1-4)- Gal binding in virulence of a wild-type strain.
Mol. Microbiol.
10:143-155[Medline].
|
| 53.
|
Ochman, H., and R. K. Selander.
1984.
Evidence for clonal population structure in Escherichia coli.
Proc. Natl. Acad. Sci. USA
81:198-201[Abstract/Free Full Text].
|
| 54.
|
Ochman, H., and R. K. Selander.
1984.
Standard reference strains of Escherichia coli from natural populations.
J. Bacteriol.
157:690-693[Abstract/Free Full Text].
|
| 55.
|
O'Hanley, P.
1996.
Prospects for urinary tract infection vaccines, p. 405-425.
In
H. L. T. Mobley, and J. W. Warren (ed.), Urinary tract infections: molecular pathogenesis and clinical management. ASM Press, Washington, D.C.
|
| 56.
|
Olesen, B.,
H. J. Kolmos,
F. Orskov, and I. Orskov.
1995.
A comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish university hospital.
J. Hosp. Infect.
31:295-305[CrossRef][Medline].
|
| 57.
|
Orskov, I., and F. Orskov.
1985.
Escherichia coli in extra-intestinal infections.
J. Hyg. (London)
95:551-575[Medline].
|
| 58.
|
Phillips, I.,
S. Eykyn,
A. King,
W. R. Grandsden,
B. Rowe,
J. A. Frost, and R. J. Gross.
1988.
Epidemic multiresistant Escherichia coli infection in West Lambeth health district.
Lancet
i:1038-1041.
|
| 59.
|
Picard, B.,
C. Journet-Mancy,
N. Picard-Pasquier, and P. Goullet.
1993.
Genetic structures of the B2 and B1 Escherichia coli strains responsible for extra-intestinal infections.
J. Gen. Microbiol.
139:3079-3088[Medline].
|
| 60.
|
Picard, B.,
J. Sevali Garcia,
S. Gouriou,
P. Duriez,
N. Brahimi,
E. Bingen,
J. Elion, and E. Denamur.
1999.
The link between phylogeny and virulence in Escherichia coli extraintestinal infection.
Infect. Immun.
67:546-553[Abstract/Free Full Text].
|
| 61.
|
Plos, K.,
S. I. Hull,
R. A. Hull,
B. R. Levin,
I. Orskov,
F. Orskov, and C. Svanborg-Edén.
1989.
Distribution of the p-associated-pilus (pap) region among Escherichia coli from natural sources: evidence for horizontal gene transfer.
Infect. Immun.
57:1604-1611[Abstract/Free Full Text].
|
| 62.
|
Prats, G.,
F. Navarro,
B. Mirelis,
D. Dalmau,
N. Margall,
P. Coll,
A. Stell, and J. R. Johnson.
2000.
Escherichia coli serotype O15:K52:H1 as a uropathogenic clone.
J. Clin. Microbiol.
38:201-209[Abstract/Free Full Text].
|
| 63.
|
Reid, S. D.,
C. J. Herbelin,
A. C. Bumbaugh,
R. K. Selander, and T. S. Whittam.
2000.
Parallel evolution of virulence in pathogenic Escherichia coli.
Nature
406:64-67[CrossRef][Medline].
|
| 64.
|
Russo, T. A.,
U. B. Carlino,
A. Mong, and S. T. Jodush.
1999.
Identification of genes in an extraintestinal isolate of Escherichia coli with increased expression after exposure to human urine.
Infect. Immun.
67:5306-5614[Abstract/Free Full Text].
|
| 65.
|
Russo, T. A., and J. R. Johnson.
2000.
A proposal for an inclusive designation for extraintestinal pathogenic Escherichia coli: ExPEC.
J. Infect. Dis.
181:1753-1754[CrossRef][Medline].
|
| 66.
|
Saitou, N., and M. Nei.
1987.
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
Mol. Biol. Evol.
4:406-425[Abstract].
|
| 67.
|
Schubert, S.,
A. Rakin,
H. Karch,
E. Carniel, and J. Heesemann.
1998.
Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans.
Infect. Immun.
66:480-485[Abstract/Free Full Text].
|
| 68.
|
Selander, R. K.,
D. A. Caugant,
H. Ochman,
J. M. Musser,
M. N. Gilmour, and T. S. Whittam.
1986.
Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.
Appl. Environ. Microbiol.
51:873-884[Free Full Text].
|
| 69.
|
Selander, R. K.,
T. K. Korhonen,
V. Väisänen-Rhen,
P. H. Williams,
P. E. Pattison, and D. A. Caugant.
1986.
Genetic relationships and clonal structure of strains of Escherichia coli causing neonatal septicemia and meningitis.
Infect. Immun.
52:213-222[Abstract/Free Full Text].
|
| 70.
|
Siitonen, A.
1994.
What makes Escherichia coli pathogenic?
Ann. Med.
26:229-231[Medline].
|
| 71.
|
Sokal, R. R., and P. H. A. Sneath.
1963.
Principles of numerical taxonomy. W. H.
Freeman, San Francisco, Calif.
|
| 72.
|
Stapleton, A., and W. E. Stamm.
1997.
Prevention of urinary tract infection.
Infect. Dis. Clin. N. Am.
11:719-733[CrossRef][Medline].
|
| 73.
|
Swenson, D. L.,
N. O. Bukanov,
D. E. Berg, and R. A. Welch.
1996.
Two pathogenicity islands in uropathogenic Escherichia coli J96: cosmid cloning and sample sequencing.
Infect. Immun.
64:3736-3743[Abstract].
|
| 74.
|
Tarr, P. I.,
S. S. Bilge,
J. C. Vary, Jr.,
S. Jelacic,
R. L. Habeeb,
T. R. Ward,
M. R. Baylor, and T. E. Besser.
2000.
Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a chromosomal region of conserved structure.
Infect. Immun.
68:1400-1407[Abstract/Free Full Text].
|
| 75.
|
Thompson, J. D.,
D. G. Higgins, and T. J. Gibson.
1994.
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680[Abstract/Free Full Text].
|
| 76.
|
Vaisanen-Rhen, V.,
J. Elo,
E. Vaisanen,
A. Siitonen,
I. Orskov,
F. Orskov,
S. B. Svenson,
P. H. Makela, and T. Korhonen.
1984.
P-fimbriated clones among uropathogenic Escherichia coli strains.
Infect. Immun.
43:149-155[Abstract/Free Full Text].
|
| 77.
|
Wang, G.,
T. S. Whittam,
C. M. Berg, and D. E. Berg.
1993.
RAPD (arbitrary primer) PCR is more sensitive than multilocus enzyme electrophoresis for distinguishing related bacterial strains.
Nucleic Acids Res.
21:5930-5933[Abstract/Free Full Text].
|
| 78.
|
Whittam, T. A., and R. A. Wilson.
1988.
Genetic relationships among pathogenic Escherichia coli of serogroup O157.
Infect. Immun.
56:2467-2473[Abstract/Free Full Text].
|
| 79.
|
Whittam, T. S.,
H. Ochman, and R. K. Selander.
1983.
Multilocus genetic structure in natural populations of Escherichia coli.
Popul. Biol.
80:1751-1755.
|
| 80.
|
Whittam, T. S.,
M. L. Wolfe, and R. A. Wilson.
1989.
Genetic relationships among Escherichia coli isolates causing urinary tract infections in humans and animals.
Epidemiol. Infect.
102:37-46[Medline].
|
Infection and Immunity, September 2001, p. 5363-5374, Vol. 69, No. 9
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5363-5374.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bultreys, A., Gheysen, I., de Hoffmann, E.
(2006). Yersiniabactin Production by Pseudomonas syringae and Escherichia coli, and Description of a Second Yersiniabactin Locus Evolutionary Group.. Appl. Environ. Microbiol.
72: 3814-3825
[Abstract]
[Full Text]
-
Johnson, J. R., Clabots, C., Rosen, H.
(2006). Effect of Inactivation of the Global Oxidative Stress Regulator oxyR on the Colonization Ability of Escherichia coli O1:K1:H7 in a Mouse Model of Ascending Urinary Tract Infection. Infect. Immun.
74: 461-468
[Abstract]
[Full Text]
-
Johnson, J. R., Scheutz, F., Ulleryd, P., Kuskowski, M. A., O'Bryan, T. T., Sandberg, T.
(2005). Phylogenetic and Pathotypic Comparison of Concurrent Urine and Rectal Escherichia coli Isolates from Men with Febrile Urinary Tract Infection. J. Clin. Microbiol.
43: 3895-3900
[Abstract]
[Full Text]
-
Bidet, P., Bonacorsi, S., Clermont, O., De Montille, C., Brahimi, N., Bingen, E.
(2005). Multiple Insertional Events, Restricted by the Genetic Background, Have Led to Acquisition of Pathogenicity Island IIJ96-Like Domains among Escherichia coli Strains of Different Clinical Origins. Infect. Immun.
73: 4081-4087
[Abstract]
[Full Text]
-
Johnson, J. R., Jelacic, S., Schoening, L. M., Clabots, C., Shaikh, N., Mobley, H. L. T., Tarr, P. I.
(2005). The IrgA Homologue Adhesin Iha Is an Escherichia coli Virulence Factor in Murine Urinary Tract Infection. Infect. Immun.
73: 965-971
[Abstract]
[Full Text]
-
Johnson, J. R., Owens, K., Sabate, M., Prats, G.
(2004). Rapid and Specific Detection of the O15:K52:H1 Clonal Group of Escherichia coli by Gene-Specific PCR. J. Clin. Microbiol.
42: 3841-3843
[Abstract]
[Full Text]
-
Johnson, J. R., O'Bryan, T. T.
(2004). Detection of the Escherichia coli Group 2 Polysaccharide Capsule Synthesis Gene kpsM by a Rapid and Specific PCR-Based Assay. J. Clin. Microbiol.
42: 1773-1776
[Abstract]
[Full Text]
-
Johnson, J. R., Gajewski, A., Lesse, A. J., Rus